ursodeoxycholic acid has been researched along with malondialdehyde in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T; Takahashi, K; Takebe, G; Uchida, K | 1 |
| Chabli, A; Colin, P; Elimadi, A; Haddad, PS; Ouazzani-Chahdi, A; Spénard, J | 1 |
| Buko, VU; Lukivskaya, O; Patsenker, E | 1 |
| Aygören, R; Günşar, C; Mir, E; Sencan, A; Türköz, E; Var, A; Vatansever, S; Yilmaz, O | 1 |
| Bi, S; Cui, H; Gao, XC; Hu, WZ; Qi, HP; Wei, SQ; Yu, NN | 1 |
| Jelic, M; Jevtovic-Stoimenov, T; Kocic, G; Nikolic, J; Sokolovic, D; Sokolovic, DM; Stanojkovic, Z; Stojanovic, M; Veljkovic, A | 1 |
| Cheng, D; Dong, JH; Guo, YJ; Jin, F; Pang, R; Tao, JY; Ye, P; Zhang, SL; Zhao, L | 1 |
| Bianciotti, LG; Contin, MD; Galleano, ML; Geréz, EM; Lucangioli, SE; Martinefski, MR; Rodriguez, MR; Tripodi, VP | 1 |
| Datta, S; De, AK; Mukherjee, A; Sana, S | 1 |
| Elshazly, SM; Mahmoud, AA | 1 |
| Akdemir, A; Erbas, O; Sahin, C; Sendag, F; Yeniel, AO | 1 |
| Cao, A; Chen, X; Chu, S; Guo, H; Peng, W; Wang, L; Zhang, X | 1 |
| Alaca, N; Çağlayan Yeğen, B; Kurtel, H; Öktem, G; Özbeyli, D; Şahin, HH; Uslu, S; Yiğittürk, G | 1 |
| Abdel-Ghaffar, A; Ahmed, EK; Ghanem, HM; Hassanin, OA; Mohamed, RG | 1 |
14 other study(ies) available for ursodeoxycholic acid and malondialdehyde
| Article | Year |
|---|---|
Rapid formation of 4-hydroxy-2-nonenal, malondialdehyde, and phosphatidylcholine aldehyde from phospholipid hydroperoxide by hemoproteins.
Topics: Aldehydes; Antioxidants; Deoxycholic Acid; Free Radicals; Hemeproteins; Hemoglobins; Hydrogen Peroxide; Lipid Metabolism; Lipid Peroxidation; Lipoproteins; Lipoxygenase; Malondialdehyde; Methemoglobin; Models, Chemical; Phosphatidylcholines; Phospholipid Ethers; Time Factors; Ultraviolet Rays; Ursodeoxycholic Acid | 2004 |
Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity.
Topics: Amiodarone; Animals; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Cells, Cultured; Dose-Response Relationship, Drug; Fatty Liver; Hepatocytes; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Nitrates; Protective Agents; Superoxides; Ursodeoxycholic Acid | 2007 |
Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Liver; Luminescent Measurements; Male; Malondialdehyde; Mitochondria; NADH Dehydrogenase; Oxidative Stress; Oxygen Consumption; Rats; Rats, Wistar; Succinate Dehydrogenase; Ursodeoxycholic Acid | 2007 |
Antibiotic treatment is superior to ursodeoxycholic acid on total parenteral nutrition associated hepatic dysfunction.
Topics: Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; Bilirubin; Caspase 3; Fas Ligand Protein; Gentamicins; Immunoenzyme Techniques; In Situ Nick-End Labeling; Liver Diseases; Malondialdehyde; Metronidazole; Oxidative Stress; Parenteral Nutrition, Total; Peroxidase; Rabbits; Ursodeoxycholic Acid | 2010 |
Ursodeoxycholic acid prevents selenite-induced oxidative stress and alleviates cataract formation: In vitro and in vivo studies.
Topics: Animals; Antioxidants; Cataract; Glutathione; Lens, Crystalline; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Sodium Selenite; Sulfhydryl Compounds; Ursodeoxycholic Acid | 2012 |
The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
Topics: Animals; Apoptosis; Catalase; Cholagogues and Choleretics; Cholestasis, Extrahepatic; Common Bile Duct; Deoxyribonuclease I; Disease Models, Animal; Endodeoxyribonucleases; Lipid Peroxidation; Liver; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Ursodeoxycholic Acid; Xanthine Oxidase | 2013 |
Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis.
Topics: Acute Disease; Alanine Transaminase; Analysis of Variance; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Cholestasis; Dexamethasone; Disease Models, Animal; Glucosides; Hydrolyzable Tannins; Liver; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Ursodeoxycholic Acid | 2013 |
Coenzyme Q in pregnant women and rats with intrahepatic cholestasis.
Topics: Animals; Bile Acids and Salts; Biomarkers; Brain; Cholestasis, Intrahepatic; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Female; Humans; Lithocholic Acid; Malondialdehyde; Muscle, Skeletal; Oxidative Stress; Pregnancy; Rats; Ubiquinone; Ursodeoxycholic Acid; Vitamin E | 2014 |
Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease.
Topics: Animals; Cholagogues and Choleretics; Colon; Drug Carriers; Inflammatory Bowel Diseases; Male; Malondialdehyde; Nanoparticles; Nitric Oxide; Particle Size; Peroxidase; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2014 |
Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Fenofibrate; Fructose; Glutathione; Glycation End Products, Advanced; Insulin; Insulin Resistance; Male; Malondialdehyde; Metabolic Syndrome; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Triglycerides; Uric Acid; Ursodeoxycholic Acid | 2014 |
Is ursodeoxycholic acid crucial for ischemia/reperfusion-induced ovarian injury in rat ovary?
Topics: Animals; Antioxidants; Female; Humans; Ischemia; Malondialdehyde; Ovarian Diseases; Ovary; Oxidative Stress; Rats; Reperfusion Injury; Torsion Abnormality; Ursodeoxycholic Acid | 2015 |
Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Blood Glucose; Catalase; Cell Survival; Cells, Cultured; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Hyperglycemia; Kidney; Male; Malondialdehyde; Mice; Mice, Mutant Strains; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase; Ursodeoxycholic Acid | 2016 |
Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Drug Therapy, Combination; Female; Hepatocytes; Liver; Liver Cirrhosis; Malondialdehyde; Peroxidase; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Silybum marianum; Stem Cells; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid suppresses the formation of fructose/streptozotocin-induced diabetic cataract in rats.
Topics: Animals; Antioxidants; Cataract; Diabetes Mellitus, Experimental; Disease Models, Animal; Fructose; Glutathione; Hyperglycemia; Insulin; Lens, Crystalline; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Ursodeoxycholic Acid | 2018 |